I'm Joe Graydon. And I'm Terry Graydon. Welcome to this podcast of the People's Pharmacy.

You can find previous podcasts and more information on a range of health topics at

people's pharmacy.com. When Nobel Prize winner, Linus Pauling, wrote vitamin C in the common cold,

he created an ongoing controversy.

This is the People's Pharmacy with Terry and Joe Graydon.

Back in the 20th century, many physicians honored Dr. Linus Pauling for his research in the field of biochemistry.

He's the only sole recipient of two Nobel Prizes, one of which was for peace.

Dr. Pauling's research about vitamin C was scorned by the medical community.

His ideas about the common cold and cancer were rejected.

Today we'll learn about the evidence on a scorebait for these conditions.

Coming up on the people's pharmacy, vitamin C studies on colds and cancer vindicate Dr. Linus Pauling.

In the People's Pharmacy Health Headlines,

Schingles vaccinations are designed to improve the immune response to the chickenpox virus and reduce the likelihood of a shingles outbreak.

A few weeks ago, we reported on studies linking

the shingles vaccine to a lower chance of developing dementia. Now, researchers have analyzed

data from South Korea on more than a million people over 50 years old. People who received a

shingles vaccine were at 25% lower risk of major cardiovascular events.

They appeared to get protection from heart failure, stroke, and heart rhythm disturbances,

as well as heart attacks. This protection was apparent for up to eight years after vaccination. The investigators suggest that

Schingles vaccine should become part of a public health strategy. According to the Alzheimer's Association,

over 7 million Americans now have Alzheimer's disease. Over the next 25 years, this form of dementia is expected to double.

There are no medications that prevent AD, and the drugs that have been approved in recent years barely slow the decline.

...